Valuation: ResMed, Inc.

Market Cap 2.92TCr 2.56TCr 2.36TCr 2.17TCr 4.1TCr 2,81600Cr 4.19TCr 28TCr 11TCr 1,37900Cr 11TCr 11TCr 4,74800Cr P/E 2026 *
19.2x
P/E 2027 * 17.4x
Enterprise Value 2.85TCr 2.49TCr 2.3TCr 2.12TCr 3.99TCr 2,74100Cr 4.08TCr 27TCr 11TCr 1,34200Cr 11TCr 10TCr 4,62100Cr EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.61x
Free-Float
75.61%
Yield 2026 *
1.2%
Yield 2027 * 1.3%
1 day-1.95%
1 week-2.37%
Current month+2.13%
1 month+6.84%
3 months-12.75%
6 months-21.39%
Current year-17.37%
1 week 190.25
Extreme 190.25
203.88
1 month 187.01
Extreme 187.01
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.95%-2.37%-22.38%-9.84% 2.92TCr
-1.91%+1.14%+25.44%+1.49% 20TCr
-0.73%+2.00%+4.24%-14.60% 15TCr
-13.29%-14.14%-32.33%-1.29% 14TCr
-1.85%-2.11%-58.12%-16.70% 6.63TCr
-2.19%-6.79%+12.82%-7.23% 5.06TCr
-0.11%+1.53%-24.62%-31.81% 4.48TCr
-2.75%-1.53%+13.64%+11.82% 3.84TCr
-2.21%-1.67%+24.67%+37.18% 3.71TCr
-4.34%-2.67%-17.41%-22.44% 2.99TCr
Average -3.12%+0.67%-7.41%-5.34% 7.86TCr
Weighted average by Cap. -3.81%+1.63%-3.69%-5.12%

Financials

2026 *2027 *
Net sales 564.98Cr 493.73Cr 455.6Cr 419.95Cr 791.53Cr 54TCr 809.1Cr 5.45TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr 602.45Cr 526.48Cr 485.82Cr 447.8Cr 844.03Cr 58TCr 862.76Cr 5.81TCr 2.28TCr 28TCr 2.26TCr 2.21TCr 98TCr
Net income 154.66Cr 135.15Cr 124.72Cr 114.96Cr 216.67Cr 15TCr 221.48Cr 1.49TCr 586.32Cr 7.29TCr 580.81Cr 568.07Cr 25TCr 167.11Cr 146.04Cr 134.76Cr 124.22Cr 234.12Cr 16TCr 239.32Cr 1.61TCr 633.54Cr 7.88TCr 627.59Cr 613.82Cr 27TCr
Net Debt -78Cr -68Cr -63Cr -58Cr -109.75Cr -7.54TCr -112.18Cr -755.05Cr -296.98Cr -3.69TCr -294.19Cr -287.73Cr -13TCr -145.68Cr -127.31Cr -117.48Cr -108.29Cr -204.1Cr -14TCr -208.64Cr -1.4TCr -552.31Cr -6.87TCr -547.12Cr -535.12Cr -24TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
17/26/17 $199.04 -1.83% 4,95,495
16/26/16 $202.76 +2.11% 10,19,540
15/26/15 $198.57 +2.88% 12,08,785
14/26/14 $193.01 -2.77% 16,22,359
13/26/13 $198.50 -2.63% 21,61,420
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
202.76USD
Average target price
249.40USD
Spread / Average Target
+23.00%

Quarterly revenue - Rate of surprise